Effects of docetaxel on antigen presentation-related functions of human monocyte-derived dendritic cells

Cancer Chemotherapy and Pharmacology

Volumn 55, Issue 5, 2005, Pages 479-487

  Nakashima, Hiroshi ^a   Tasaki, Akira ^a   Kubo, Makoto ^a   Kuroki, Hideo ^a   Matsumoto, Kotaro ^a   Tanaka, Masao ^a   Nakamura, Masafumi ^a   Morisaki, Takashi ^a   Katano, Mitsuo ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Directional migration; Immunotherapy; Microtubules; Non directional migration; Taxane

Indexed keywords

CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR7; DOCETAXEL; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; CELL COUNT; CELL FUNCTION; CELL MATURATION; CELL MOTILITY; CELL ORGANELLE; CELL STRUCTURE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSKELETON; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOTOXICITY; MICROTUBULE ASSEMBLY; MONOCYTE; NORMAL HUMAN; PHAGOCYTOSIS; PODOSOME; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL SURVIVAL; DENDRITIC CELLS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; IMMUNOTHERAPY; MICROTUBULES; MONOCYTES; NEOPLASMS; PHAGOCYTOSIS; TAXOIDS;

EID: 17644362285     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-004-0918-7     Document Type: Article

References (44)

1. Axel DI, Kunert W, Goggelmann C, Oberhoff M, Herdeg C, Kuttner A, Wild DH, Brehm BR, Riessen R, Koveker G, Karsch KR (1997) Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery. Circulation 96:636
2. Banchereau J, Steinman RM (1998) Dendritic cells and the control of immunity. Nature 392:245
3. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, Pulendran B, Palucka K (2000) Immunobiology of dendritic cells. Annu Rev Immunol 18:767
4. Banchereau J, Palucka AK, Dhodapkar M, Burkeholder S, Taquet N, Rolland A, Taquet S, Coquery S, Wittkowski KM, Bhardwaj N, Pineiro L, Steinman R, Fay J (2001) Immune and clinical responses in patients with metastatic melanoma to CD34( + ) progenitor-derived dendritic cell vaccine. Cancer Res 61:6451
5. Belotti D, Rieppi M, Nicoletti MI, Casazza AM, Fojo T, Taraboletti G, Giavazzi R (1996) Paclitaxel (Taxol) inhibits motility of paclitaxel-resistant human ovarian carcinoma cells. Clin Cancer Res 2:175
6. Bruno R, Vergniol JC, Montay G (1992) Clinical pharmacology of taxotere (RP 56976) given as 1-2 hr infusion every 2-3 weeks. Proc Am Assoc Cancer Res 32:261
7. Burns S, Hardy SJ, Buddle J, Yong KL, Jones GE, Thrasher AJ (2004) Maturation of DC is associated with changes in motile characteristics and adherence. Cell Motil Cytoskeleton 57:118
8. Caux C, Ait-Yahia S, Chemin K, de Bouteiller O, Dieu-Nosjean MC, Homey B, Massacrier C, Vanbervliet B, Zlotnik A, Vicari A (2000) Dendritic cell biology and regulation of dendritic cell trafficking by chemokines. Springer Semin Immunopathol 22:345
9. Cella M, Sallusto F, Lanzavecchia A (1997) Origin, maturation and antigen presenting function of dendritic cells. Curr Opin Immunol 9:10
10. Derry WB, Wilson L, Jordan MA (1995) Substoichiometric binding of taxol suppresses microtubule dynamics. Biochemis-try 34:2203
11. Engleman EG, Fong L (2003) Induction of immunity to tumorassociated antigens following dendritic cell vaccination of cancer patients. Clin Immunol 106:10
12. Evans JG, Correia I, Krasavina O, Watson N, Matsudaira P (2003) Macrophage podosomes assemble at the leading lamella by growth and fragmentation. J Cell Biol 161:697
13. Fong L, Engleman EG (2000) Dendritic cells in cancer immunotherapy. Annu Rev Immunol 18:245
14. Gelmon K (1994) The taxoids: paclitaxel and docetaxel. Lancet 344:1267
15. Glasgow JE, Daniele RP (1994) Role of microtubules in random cell migration: stabilization of cell polarity. Cell Motil Cytoskeleton 27:88
16. Gluck S (2001) The worldwide perspective in the adjuvant treatment of primary lymph node positive breast cancer. Breast Cancer 8:321
17. Goodsell DS (2000) The molecular perspective: microtubules and the taxanes. Oncologist 5:345
18. Herrin VE, Thigpen JT (1999) Chemotherapy for ovarian cancer: current concepts. Semin Surg Oncol 17:181
19. Hortobagyi GN (1999) Recent progress in the clinical development of docetaxel (Taxotere). Semin Oncol 26(3 Suppl 9):32
20. Hortobagyi GN (2002) Integration of docetaxel into adjuvant breast cancer treatment regimens. Oncology (Huntingt) 16(6 Suppl 6):27
21. Hotchkiss KA, Ashton AW, Mahmood R, Russell RG, Sparano JA, Schwartz EL (2002) Inhibition of endothelial cell function in vitro and angiogenesis in vivo by docetaxel (Taxotere): association with impaired repositioning of the microtubule organizing center. Mol Cancer Ther 1:1191
22. Kellermann SA, Hudak S, Oldham ER, Liu YJ, McEvoy LM (1999) The CC chemokine receptor-7 ligands 6Ckine and macrophage inflammatory protein-3 beta are potent chemoattractants for in vitro- and in vivo-derived dendritic cells. J Immunol 162:3859
23. Kris MG, Tonato M (2002) New approaches in the treatment of non-small cell lung cancer: taxanes in the treatment of NSCLC: pathways to progress. Lung Cancer 38 [Suppl 4]:1
24. Kuroki H, Morisaki T, Matsumoto K, Onishi H, Baba E, Tanaka M, Katano M (2003) Streptococcal preparation OK-432: a new maturation factor of monocyte-derived dendritic cells for clinical use. Cancer Immunol Immunother 24:4443
25. Linder S, Aepfelbacher M (2003) Podosomes: adhesion hotspots of invasive cells. Trends Cell Biol 13:376
26. Linder S, Hufner K, Wintergerst U, Aepfelbacher M (2000) Microtubule-dependent formation of podosomal adhesion structures in primary human macrophages. J Cell Sci 113:4165
27. Luft T, Jefford M, Luetjens P, Toy T, Hochrein H, Masterman KA, Maliszewski C, Shortman K, Cebon J, Maraskovsky E (2002) Functionally distinct dendritic cell (DC) populations induced by physiologic stimuli: prostaglandin E(2) regulates the migratory capacity of specific DC subsets. Blood 100:1362
28. Morse MA, Lyerly HK (2000) Dendritic cell-based immunization for cancer therapy. Adv Exp Med Biol 465:335
29. Morse MA, Zhou LJ, Tedder TF, Lyerly HK, Smith C (1997) Generation of dendritic cells in vitro from peripheral blood mononuclear cells with granulocyte-macrophage-colony-stimulating factor, interleukin-4, and tumor necrosis factor-alpha for use in cancer immunotherapy. Ann Surg 226:6
30. Obasaju C, Hudes GR (2001) Paclitaxel and docetaxel in prostate cancer. Hematol Oncol Clin North Am 15:525
31. Onishi H, Morisaki T, Baba E, Kuga H, Kuroki H, Matsumoto K, Tanaka M, Katano M (2002) Dysfunctional and short-lived subsets in monocyte-derived dendritic cells from patients with advanced cancer. Clin Immunol 105:286
32. Roberts RL, Nath J, Friedman MM, Gallin JI (1982) Effects of taxol on human neutrophils. J Immunol 129:2134
33. Rodriguez OC, Schaefer AW, Mandate CA, Forscher P, Bernent WM, Waterman-Storer CM (2003) Conserved microtubule-actin interactions in cell movement and morphogenesis. Nat Cell Biol 5:599
34. Shutt DC, Daniels KJ, Carolan EJ, Hill AC, Soll DR (2000) Changes in the motility, morphology, and F-actin architecture of human dendritic cells in an in vitro model of dendritic cell development. Cell Motil Cytoskeleton 46:200
35. Small JV, Geiger B, Kaverina I, Bershadsky A (2002) How do microtubules guide migrating cells? Nat Rev Mol Cell Biol 3:957
36. Swetman CA, Leverrier Y, Garg R, Gan CH, Ridley AJ, Katz DR, Chain BM (2002) Extension, retraction and contraction in the formation of a dendritic cell dendrite: distinct roles for Rho GTPases. Eur J Immunol 32:2074
37. Terzis AJ, Thorsen F, Heese O, Visted T, Bjerkvig R, Dahl O, Arnold H, Gundersen G (1997) Proliferation, migration and invasion of human glioma cells exposed to paclitaxel (Taxol) in vitro. Br J Cancer 75:1744
38. Trinchieri G (1995) Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridges innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 13:251
39. Tsavaris N, Kosmas C, Vadiaka M, Kanelopoulos P, Boulamatsis D (2002) Immune changes in patients with advanced breast cancer undergoing chemotherapy with taxanes. Br J Cancer 87:21
40. Westerlund A, Hujanen E, Hoyhtya M, Puistola U, Turpeenniemi-Hujanen T (1997) Ovarian cancer cell invasion is inhibited by paclitaxel. Clin Exp Metastasis 15:318
41. Yu B, Kusmartsev S, Cheng F, Paolini M, Nefedova Y, Sotomayor E, Gabrilovich D (2003) Effective combination of chemotherapy and dendritic cell administration for the treatment of advanced-stage experimental breast cancer. Clin Cancer Res 9:285
42. Zhang H, Morisaki T, Nakahara C, Matsunaga H, Sato N, Nagumo F, Tadano J, Katano M (2003) PSK-mediated NF-kappaB inhibition augments docetaxel-induced apoptosis in human pancreatic cancer cells NOR-P1. Oncogene 22:2088
43. Zhou LJ, Tedder TF (1996) CD14+ blood monocytes can differentiate into functionally mature CD83 + dendritic cells. Proc Natl Acad Sci U S A 93:2588
44. Zlotnik A, Yoshie O (2000) Chemokines: a new classification system and their role in immunity. Immunity 12:127